malondialdehyde has been researched along with Wallerian Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erol, FS; Ilhan, N; Kaplan, M; Ozercan, I; Tiftikci, M; Topsakal, C; Yakar, H | 1 |
1 other study(ies) available for malondialdehyde and Wallerian Degeneration
Article | Year |
---|---|
Comparison of the effects of octreotide and melatonin in preventing nerve injury in rats with experimental spinal cord injury.
Topics: Animals; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Gastrointestinal Agents; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Injections, Intraperitoneal; Male; Malondialdehyde; Melatonin; Necrosis; Nerve Degeneration; Neuroprotective Agents; Octreotide; Oxidative Stress; Rats; Rats, Wistar; Spinal Cord Injuries; Superoxide Dismutase; Superoxide Dismutase-1; Treatment Outcome; Wallerian Degeneration | 2008 |